The following is a sample from a larger document.
This section is for: Domain and Overview
The section is from a Focused Issue Brief on: Assessing Scientific Causation Claims in PFAS Exposure Litigation
The primary research jurisdiction is: United States of America
Section 2: Domain Overview
PFAS stands for per- and polyfluoroalkyl substances, a class of synthetic chemicals engineered to resist heat, water, and oil. The carbon-fluorine bond defines these compounds—one of the strongest single bonds in organic chemistry. This bond makes PFAS exceptionally stable and persistent. They degrade extremely slowly under most environmental and biological conditions, earning them the nickname “forever chemicals.”
Thousands of individual compounds make up the PFAS class, each with different molecular structures and properties. PFOA (perfluorooctanoic acid) and PFOS (perfluorooctane sulfonic acid) have received the most study and regulation, though PFNA, PFHxS, and GenX chemicals are gaining attention. These chemicals share the fluorinated carbon chain structure but differ in chain length and functional groups.
Manufacturers first developed PFAS in the 1940s and found widespread use because of their unique properties. They repel both water and oil, resist high temperatures, and create non-stick surfaces. Firefighting foam, non-stick cookware, water-resistant clothing, food packaging, industrial processes, and hundreds of other applications rely on these characteristics.
The same properties that make PFAS useful create their environmental and health concerns.
Because they do not degrade naturally, PFAS accumulate in the environment over time. They move readily through water systems, traveling through soil and groundwater. They bioaccumulate in organisms, meaning concentrations increase as they move up the food chain. In humans, PFAS bind to proteins in blood and organs, particularly concentrating in the liver and kidneys, with elimination half-lives measured in years rather than days or weeks.
How PFAS Move Through Environmental Systems
PFAS enter the environment through multiple pathways. Industrial facilities discharge PFAS-containing wastewater directly into water bodies or through treatment plants not equipped to remove these chemicals. Firefighting training sites and airports where personnel used aqueous film-forming foam (AFFF) heavily contaminate surrounding soil and groundwater. Landfills receiving PFAS-containing products can release PFAS into groundwater through leachate if not effectively captured and treated. Wastewater treatment plants receive PFAS from industrial and residential sources and often are not designed to remove them effectively, so treated effluent may carry PFAS into receiving waters.
PFAS behavior once released depends on their specific molecular structure. Longer-chain PFAS like PFOA and PFOS bind more strongly to soil particles and accumulate in sediments, though they remain mobile enough to travel significant distances. Shorter-chain PFAS move more readily through water systems and bind less to soil, making them more difficult to contain but also less likely to bioaccumulate to the same degree.
Groundwater contamination represents a particularly persistent exposure pathway. PFAS move through soil and into aquifers, where they can travel significant distances from the original source depending on hydrogeologic conditions. Because groundwater moves slowly and PFAS do not degrade, contamination plumes can persist and expand for decades. Wells drawing from contaminated aquifers become long-term exposure sources for entire communities.
Surface water systems distribute PFAS widely. Rivers, lakes, and coastal waters receive PFAS from industrial discharges, contaminated groundwater, and atmospheric deposition. These waters then serve as sources for drinking water supplies and irrigation systems, creating widespread exposure networks.
Human Exposure Pathways and Measurement
Humans encounter PFAS through several distinct routes, each presenting different exposure patterns and measurement challenges. The route, timing, and duration of exposure affect both the biological response and the strength of causal inference.
Drinking water represents the most significant and measurable exposure source for most populations. Laboratories can precisely quantify PFAS concentrations in drinking water using established analytical methods. Public water systems are increasingly required to monitor for PFAS under recent federal and state regulations, creating exposure data that can be linked to specific populations over defined time periods. Private wells in contaminated areas often show higher concentrations than public supplies, as they lack treatment systems and regulatory oversight.
Dietary exposure occurs through food and food packaging. PFAS accumulate in fish, shellfish, and livestock that consume contaminated water or feed. Food packaging made with PFAS-treated materials can transfer chemicals to food contents, particularly with heat or acidic foods. This pathway is more difficult to quantify because it depends on individual dietary patterns and the specific PFAS content of consumed products.
Workers in industries that manufacture, use, or dispose of PFAS-containing materials face occupational exposure that typically exceeds environmental levels by orders of magnitude. These exposures occur through inhalation of dusts or vapors and dermal contact with contaminated materials. Occupational settings provide the highest documented human exposures and often the strongest exposure-response data.
Consumer product exposure happens through direct contact with PFAS-treated materials. Non-stick cookware, stain-resistant fabrics, cosmetics, and other treated products can transfer PFAS to users. These exposures are generally low-level but chronic, occurring repeatedly over years of product use.
Indoor air and dust represent emerging exposure pathways. PFAS off-gas from treated carpets, furniture, and other indoor materials, accumulating in house dust that residents inhale or accidentally ingest. Young children face higher exposure through this pathway due to hand-to-mouth behavior.
Biomonitoring and Exposure Assessment
Measuring PFAS exposure in humans relies primarily on blood serum concentrations, which reflect accumulated exposure over months to years depending on the specific PFAS compound. Blood levels integrate exposure from all sources and routes, providing a biological measure of total body burden.
PFAS measurement in blood uses liquid chromatography coupled with mass spectrometry. These methods can detect PFAS at very low concentrations (often in the parts-per-trillion range) with high precision and accuracy under validated laboratory conditions. However, the methods are expensive and require specialized laboratories, limiting the frequency and scope of biomonitoring studies.
Different PFAS compounds have different elimination half-lives in humans. PFOA and PFOS have reported elimination half-lives in humans generally on the order of several years (often estimated around 2–4 years for PFOA and 4–7 years for PFOS), meaning blood levels reflect exposure accumulated over multiple years. Shorter-chain PFAS eliminate more rapidly, with half-lives of weeks to months, so blood levels more closely reflect recent exposure.
The general U.S. population shows detectable levels of multiple PFAS compounds, with median serum concentrations in the low parts-per-billion range for PFOA and PFOS. However, individuals near contaminated sites may have concentrations 10-100 times higher than background levels.
Exposure assessment faces several methodological challenges relevant to causation claims. Retrospective exposure estimation requires modeling historical exposures based on limited data about past sources, environmental conditions, and individual behaviors. When surrogate measures (like residential proximity to contamination) do not accurately reflect individual exposure levels, exposure misclassification can occur. Multiple PFAS exposures complicate attribution of health effects to specific compounds.
Health Endpoints and Biological Mechanisms
PFAS health research focuses on endpoints where biological plausibility and epidemiological evidence suggest causal relationships. Regulatory agencies have identified elevated cholesterol levels, decreased immune function, certain liver effects, kidney cancer, testicular cancer, pregnancy-induced hypertension, and ulcerative colitis as health outcomes of concern based on varying degrees of epidemiological evidence and assessments of biological plausibility.
PFAS bind to proteins throughout the body, particularly albumin in blood and fatty acid-binding proteins in tissues. This binding affects normal physiological processes and may explain some observed health effects, though the complete pathway from exposure to disease remains incompletely understood for most endpoints.
Liver effects appear most consistently across studies and show the clearest dose-response relationships.
PFAS accumulate in liver tissue and affect lipid metabolism, leading to elevated cholesterol and triglycerides. They may also cause liver inflammation and cellular damage at high exposure levels. PFAS undergo hepatic processing and biliary excretion as part of their elimination, potentially contributing to observed liver-related effects at certain exposure levels.
Immune system effects include reduced antibody responses to vaccines and increased susceptibility to infections. PFAS may interfere with immune cell function and development, though researchers continue investigating the specific mechanisms. These effects have particular significance given widespread vaccination programs and infectious disease concerns.
Endocrine disruption represents another proposed mechanism, with PFAS potentially interfering with hormone production, transport, and signaling. This could explain reproductive and developmental effects observed in some studies, though the evidence for endocrine disruption remains mixed across different PFAS compounds and endpoints.
Cancer mechanisms focus primarily on kidney and testicular cancers, where some epidemiological studies suggest associations with PFOA exposure. However, PFAS do not appear to damage DNA directly. Instead, proposed cancer mechanisms involve chronic inflammation, oxidative stress, and interference with normal cellular processes that regulate growth and division.
Regulatory Framework and Standards
Multiple agencies operating under different statutory authorities create a complex regulatory framework for PFAS standards and remediation.
Under the Safe Drinking Water Act, EPA finalized maximum contaminant levels of 4 parts per trillion for both PFOA and PFOS in 2024, with phased monitoring and compliance requirements beginning in the following years. The Clean Water Act governs industrial discharges, and EPA has begun setting effluent limitations for facilities that manufacture or use PFAS. Through CERCLA, EPA designated PFOA and PFOS as hazardous substances in 2024, making releases of these chemicals subject to reporting requirements and potential cleanup liability.
Several states have established drinking water standards for PFAS below EPA levels, with some setting standards for additional PFAS compounds not covered by federal rules. State environmental agencies also regulate industrial discharges and groundwater contamination under state authorities.
EPA’s health advisory levels represent concentrations below which adverse health effects are not expected over a lifetime of exposure, but these advisories are not legally enforceable standards.
EPA and other organizations have standardized analytical methods for PFAS measurement. These methods specify sample collection, preservation, analysis, and quality control procedures that laboratories must follow to produce legally defensible data. The methods can detect PFAS at very low concentrations but require sophisticated equipment and expertise.
Temporal and Geographic Patterns
PFAS contamination and exposure patterns vary significantly across time and geography, affecting how causation claims can be established and defended.
Industrial manufacturing sites, particularly facilities that produced PFAS chemicals, typically show the highest contamination levels. Military installations and airports where personnel used firefighting foam extensively represent another major contamination category. These sites often contaminated large groundwater plumes affecting surrounding communities.
Communities near contaminated sites experience much higher exposures than background populations, providing the exposure gradients needed to detect health effects. However, this clustering also means that exposure often correlates with other potential risk factors like industrial activity, military presence, or socioeconomic factors.
PFAS production and use of certain long-chain compounds were highest in the 1990s and early 2000s before major manufacturers began phasing out some longer-chain compounds. Environmental releases peaked during this period, with contamination spreading through environmental systems over subsequent years. Human exposures generally followed environmental contamination with some delay, as PFAS moved through water systems and food chains.
Exposure trends in the general population show declining concentrations of PFOA and PFOS in blood since the early 2000s, reflecting industry phase-outs and regulatory actions. However, concentrations of replacement chemicals are increasing, and environmental contamination persists due to the chemicals’ persistence.
Historical exposures must often be estimated using models that incorporate environmental fate and transport, industrial use patterns, and demographic data. The accuracy of these estimates affects the strength of exposure-response relationships and, ultimately, causation claims.